ANVS
Price
$10.18
Change
-$0.47 (-4.41%)
Updated
Dec 7, 2:58 PM EST
116 days until earnings call
CRBP
Price
$5.40
Change
-$0.54 (-9.09%)
Updated
Dec 7, 6:59 PM EST
Ad is loading...

Analysis and predictions ANVS vs CRBP

Header iconANVS vs CRBP Comparison
Open Charts ANVS vs CRBPBanner chart's image
Annovis Bio
Price$10.18
Change-$0.47 (-4.41%)
Volume$200
CapitalizationN/A
Corbus Pharmaceuticals Holdings
Price$5.40
Change-$0.54 (-9.09%)
Volume$16.68K
CapitalizationN/A
View a ticker or compare two or three
ANVS vs CRBP Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ANVS vs. CRBP commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Buy and CRBP is a Hold.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (ANVS: $10.68 vs. CRBP: $5.40)
Brand notoriety: ANVS and CRBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 235% vs. CRBP: 115%
Market capitalization -- ANVS: $75.84M vs. CRBP: $18.62M
ANVS [@Biotechnology] is valued at $75.84M. CRBP’s [@Biotechnology] market capitalization is $18.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileCRBP’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • CRBP’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANVS and CRBP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while CRBP’s TA Score has 4 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 5 bearish.
  • CRBP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than CRBP.

Price Growth

ANVS (@Biotechnology) experienced а +28.52% price change this week, while CRBP (@Biotechnology) price change was -19.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.16%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was +25.31%.

Reported Earning Dates

ANVS is expected to report earnings on Apr 01, 2024.

CRBP is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+6.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ANVS with price predictions.
OPEN
A.I.dvisor published
a Summary for CRBP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ANVS($75.8M) has a higher market cap than CRBP($18.6M). CRBP YTD gains are higher at: 62.896 vs. ANVS (-20.477). CRBP has higher annual earnings (EBITDA): -37.82M vs. ANVS (-42.39M). CRBP has more cash in the bank: 28.7M vs. ANVS (6.36M). ANVS has less debt than CRBP: ANVS (500K) vs CRBP (22.9M). ANVS (0) and CRBP (0) have equivalent revenues.
ANVSCRBPANVS / CRBP
Capitalization75.8M18.6M408%
EBITDA-42.39M-37.82M112%
Gain YTD-20.47762.896-33%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.36M28.7M22%
Total Debt500K22.9M2%
FUNDAMENTALS RATINGS
CRBP: Fundamental Ratings
CRBP
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSCRBP
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 30 days ago
89%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOPS15.922.76
+20.97%
TOP Ships
COFS27.120.44
+1.65%
ChoiceOne Financial Services
BGC6.36-0.02
-0.31%
BGC Group
AVB174.99-0.77
-0.44%
AvalonBay Communities
HY49.68-0.39
-0.78%
Hyster-Yale Materials Handling

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with MDGL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+3.69%
MDGL - ANVS
36%
Loosely correlated
+0.54%
CYTK - ANVS
32%
Poorly correlated
+2.67%
VTYX - ANVS
32%
Poorly correlated
+3.08%
AXON - ANVS
31%
Poorly correlated
+0.27%
ASND - ANVS
31%
Poorly correlated
+0.76%
More